June 17, 2020 / 12:27 PM / 18 days ago

BRIEF-Kiniksa Announces Lancet Rheumatology Publication Of Clinical Outcomes With Mavrilimumab In Covid-19

June 17 (Reuters) - Kiniksa Pharmaceuticals Ltd:

* KINIKSA PHARMACEUTICALS - ANNOUNCES LANCET RHEUMATOLOGY PUBLICATION OF CLINICAL OUTCOMES WITH MAVRILIMUMAB IN COVID-19

* KINIKSA PHARMACEUTICALS - YESCARTA PHASE 2 TRIAL EXPECTED TO COMMENCE IN H2 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below